XML 26 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY:
6 Months Ended
Sep. 30, 2017
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY:  
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY:
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS’ EQUITY:
 
Earnings (Loss) Per Share
 
A reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share is shown below (in thousands, except per share amounts): 
 
 
For the three months ended
 
For the six months ended
 
 
September 30,
 
September 30,
 
 
2017
 
2016
 
2017
 
2016
Basic earnings (loss) per share:
 
 
 
 

 
 
 
 

Net earnings (loss)
 
$
(3,336
)
 
$
7,140

 
$
(4,636
)
 
$
11,116

 
 
 
 
 
 
 
 
 
Basic weighted-average shares outstanding
 
79,235

 
77,446

 
78,954

 
77,459


 
 

 
 

 
 

 
 

Basic earnings (loss) per share
 
$
(0.04
)
 
$
0.09

 
$
(0.06
)
 
$
0.14

 
 
 
 
 
 
 
 
 
Diluted earnings (loss) per share:
 
 

 
 

 
 

 
 

Basic weighted-average shares outstanding
 
79,235

 
77,446

 
78,954

 
77,459

Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method
 

 
1,831

 

 
1,858

Diluted weighted-average shares outstanding
 
79,235

 
79,277

 
78,954

 
79,317


 
 

 
 

 
 

 
 

Diluted earnings (loss) per share
 
$
(0.04
)
 
$
0.09

 
$
(0.06
)
 
$
0.14


 
Due to the net loss incurred by the Company during the three and six months ended September 30, 2017, the dilutive effect of options, warrants and restricted stock units covering 2.2 million and 2.5 million shares of common stock, respectively, was excluded from the diluted loss per share calculation since the impact on the calculation was anti-dilutive.
 
Additional options and warrants to purchase shares of common stock and restricted stock units that were outstanding during the periods presented but were not included in the computation of diluted earnings (loss) per share because the effect was anti-dilutive are shown below (in thousands, except per share amounts): 
 
 
For the three months ended
 
For the six months ended
 
 
September 30,
 
September 30,
 
 
2017
 
2016
 
2017
 
2016
Number of shares outstanding under options, warrants and restricted stock units
 
1,308

 
39

 
324

 
263

Range of exercise prices for options
 
$32.85

 
$20.27-$32.85

 
$32.85

 
$20.27-$32.85


 
Stockholders’ Equity
 
On August 29, 2011, the board of directors adopted a common stock repurchase program.  That program was subsequently modified and expanded, most recently on July 28, 2016.  Under the modified common stock repurchase program, the Company may purchase up to $400.0 million of its common stock through the period ending June 30, 2018. During the six months ended September 30, 2017, the Company repurchased 0.9 million shares of its common stock for $19.8 million.  Through September 30, 2017, the Company had repurchased a total of 17.7 million shares of its stock for $305.5 million, leaving remaining capacity of $94.5 million under the stock repurchase program.
 
Accumulated Other Comprehensive Income
 
Accumulated other comprehensive income accumulated balances of $9.4 million and $8.0 million at September 30, 2017 and March 31, 2017, respectively, reflect accumulated foreign currency translation adjustments.